Mednet Logo
HomeMedical OncologyQuestion

What is the duration of AI that you use in men with hormone receptor-positive early stage breast cancer?

1 Answers
Mednet Member
Mednet Member
Medical Oncology · MOSC Medical College Kolenchery

There are no prospectively conducted studies in men with breast cancer. We extrapolate data from adjuvant breast cancer trials with tamoxifen which were conducted in women. Based on some retrospective data, tamoxifen is deemed to be the safe and effective option in men. However, in metastatic breast...

Register or Sign In to see full answer